Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Trippoli

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|October 28, 1999
Cost effectiveness of riluzole in amyotrophic lateral sclerosis. Italian Cooperative Group for the Study of Meta-Analysis and the Osservatorio SIFO sui FarmaciA Messori, S Trippoli, P Becagli, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancerA Messori, P Becagli, S Trippoli, et al.
Anti-Cancer Drugs|December 29, 2000
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrolA Messori, F Cattel, S Trippoli, et al.
Oncology Reports|October 14, 1998
Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluationS Trippoli, A Messori, P Becagli, et al.
European Journal of Clinical Pharmacology|December 20, 2003
Dropout rates with olanzapine or risperidone: a multi-centre observational studyF Pelagotti, B Santarlasci, F Vacca, et al.
BMJ (Clinical Research Ed.)|November 4, 2000
Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trialsA Messori, S Trippoli, M Vaiani, et al.
Haematologica|July 17, 2001
Multivariate analysis of factors influencing quality of life and utility in patients with haemophiliaS Trippoli, M Vaiani, S Linari, et al.
British Journal of Cancer|February 13, 2001
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOPA Messori, M Vaiani, S Trippoli, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysisA Messori, S Trippoli, P Becagli, et al.
Oncology Reports|May 19, 2011
Cost-effectiveness of neoadjuvant multimodal therapy in patients with esophageal adenocarcinomaI Davini, P Becagli, M Pani, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|October 28, 1999
Cost effectiveness of riluzole in amyotrophic lateral sclerosis. Italian Cooperative Group for the Study of Meta-Analysis and the Osservatorio SIFO sui FarmaciA Messori, S Trippoli, P Becagli, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancerA Messori, P Becagli, S Trippoli, et al.
Anti-Cancer Drugs|December 29, 2000
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrolA Messori, F Cattel, S Trippoli, et al.
Oncology Reports|October 14, 1998
Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluationS Trippoli, A Messori, P Becagli, et al.
European Journal of Clinical Pharmacology|December 20, 2003
Dropout rates with olanzapine or risperidone: a multi-centre observational studyF Pelagotti, B Santarlasci, F Vacca, et al.
BMJ (Clinical Research Ed.)|November 4, 2000
Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trialsA Messori, S Trippoli, M Vaiani, et al.
Haematologica|July 17, 2001
Multivariate analysis of factors influencing quality of life and utility in patients with haemophiliaS Trippoli, M Vaiani, S Linari, et al.
British Journal of Cancer|February 13, 2001
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOPA Messori, M Vaiani, S Trippoli, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysisA Messori, S Trippoli, P Becagli, et al.
Oncology Reports|May 19, 2011
Cost-effectiveness of neoadjuvant multimodal therapy in patients with esophageal adenocarcinomaI Davini, P Becagli, M Pani, et al.
Pageof 3